重组Anti-PU.1/Spi1抗体[EPR25123-110]
Anti-PU.1/Spi1 antibody [EPR25123-110]
- BOND RX™ Validated
- 20ul selling size
- RabMAb
- Advanced Validation
- Recombinant
- 了解详情
Be the first to review this product! Submit a review
|
(5 Publications)
Rabbit Recombinant Monoclonal PU.1/Spi1 antibody. Suitable for ChIP, IP, Flow Cyt (Intra), ICC/IF, IHC-P, WB, ChIC/CUT&RUN-seq and reacts with Human samples. Cited in 5 publications.
查看别名
Transcription factor PU.1, 31 kDa-transforming protein, SPI1
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-PU.1/Spi1 antibody [EPR25123-110] (AB302623)
Immunofluorescent analysis of 4% Paraformaldehyde-fixed, 0.1% TritonX-100 permeabilized THP-1 (human monocytic leukemia monocyte) cells labelling PU.1/Spi1 with ab302623 at 1/250 (1.868 ug/ml) dilution, followed by ab150081 Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed antibody at 1/1000 2ug/mL dilution (Green). Confocal image showing nuclear staining in THP-1 cell line.Negative control : Hela (PMID : 27010793) is observed. ab195889 Anti-alpha Tubulin mouse monoclonal antibody - Microtubule Marker (Alexa Fluor® 594) was used to counterstain tubulin at 1/200 2.5ug/ml dilution (Red). The Nuclear counterstain was DAPI (Blue). Secondary antibody only control : Secondary antibody is ab150081 Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed at 1/1000 2ug/mL dilution.
- Flow Cyt (Intra)
Supplier Data
Flow Cytometry (Intracellular) - Anti-PU.1/Spi1 antibody [EPR25123-110] (AB302623)
Flow cytometric analysis of 4% paraformaldehyde fixed 90% methanol permeabilized THP-1 (human monocytic leukemia monocyte) cells labelling PU.1/Spi1 with ab302623 at 1/500 dilution (0.1ug) (Red) (Red) compared with a Rabbit monoclonal IgG (ab172730) (Black) isotype control and an unlabelled control (cells without incubation with primary antibody and secondary antibody) (Blue). A Goat Anti-Rabbit IgG (Alexa Fluor® 488, ab150081) at 1/2000 dilution was used as the secondary antibody.
- Flow Cyt (Intra)
Supplier Data
Flow Cytometry (Intracellular) - Anti-PU.1/Spi1 antibody [EPR25123-110] (AB302623)
Flow cytometric analysis of 4% paraformaldehyde fixed 90% methanol permeabilized HeLa (human cervix adenocarcinoma epithelial cell, Left) / U937 (human histiocytic lymphoma monocyte, Right) cells labelling PU.1/Spi1 with ab302623 at 1/500 dilution (0.1ug) (Red) (Red) compared with a Rabbit monoclonal IgG (ab172730) (Black) isotype control and an unlabelled control (cells without incubation with primary antibody and secondary antibody) (Blue). A Goat Anti-Rabbit IgG (Alexa Fluor® 488, ab150081) at 1/2000 dilution was used as the secondary antibody. Negative control : HeLa (PMID : 27010793)
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PU.1/Spi1 antibody [EPR25123-110] (AB302623)
Immunohistochemical analysis of paraffin-embedded Human colon tissue labeling PU.1/Spi1 with ab302623 at 1/1000 (0.467 ug/ml) followed by a ready to use LeicaDS9800 (Bond Polymer Refine Detection) was used. Positive staining in immune cells of human colon (PMID : 28681454). The section was incubated with ab302623 for 30 mins at room temperature. The immunostaining was performed on a Leica Biosystems BOND® RX instrument. Counterstained with Hematoxylin. Secondary antibody only control : Secondary antibody is a ready to use LeicaDS9800 (Bond Polymer Refine Detection) was used. Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0, epitope retrieval solution2) for 20 mins
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-PU.1/Spi1 antibody [EPR25123-110] (AB302623)
Immunofluorescent analysis of 4% Paraformaldehyde-fixed, 0.1% TritonX-100 permeabilized U-937 (human histiocytic lymphoma monocyte) cells labelling PU.1/Spi1 with ab302623 at 1/250 (1.868 ug/ml) dilution, followed by ab150081 Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed antibody at 1/1000 2ug/mL dilution (Green). Confocal image showing nuclear staining in U-937 cell line. is observed. ab195889 Anti-alpha Tubulin mouse monoclonal antibody - Microtubule Marker (Alexa Fluor® 594) was used to counterstain tubulin at 1/200 2.5ug/ml dilution (Red). The Nuclear counterstain was DAPI (Blue). Secondary antibody only control : Secondary antibody is ab150081 Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed at 1/1000 2ug/mL dilution.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PU.1/Spi1 antibody [EPR25123-110] (AB302623)
Immunohistochemical analysis of paraffin-embedded Human diffuse large tissue labeling PU.1/Spi1 with ab302623 at 1/1000 (0.467 ug/ml) followed by a ready to use LeicaDS9800 (Bond Polymer Refine Detection) was used. Positive staining in human diffuse large B-cell lymphoma (PMID : 16648862). The section was incubated with ab302623 for 30 mins at room temperature. The immunostaining was performed on a Leica Biosystems BOND® RX instrument. Counterstained with Hematoxylin. Secondary antibody only control : Secondary antibody is a ready to use LeicaDS9800 (Bond Polymer Refine Detection) was used. Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0, epitope retrieval solution2) for 20 mins
- ChIP
Lab
ChIP - Anti-PU.1/Spi1 antibody [EPR25123-110] (AB302623)
Chromatin was prepared from U-937 cells according to the Abcam Dual-X-ChIP protocol. Cells were fixed with 1.5 mM EGS for 30mins and then formaldehyde for 10min. The ChIP was performed with 25 µg of chromatin, 5 µg of ab302623 (red), or 5 µg of rabbit normal IgG ab172730 (gray) and 25 µl of Protein A/G Dynabeads. The immunoprecipitated DNA was quantified by real time PCR (Sybr green approach).
Primers and probes are from paper PMID : 21402070, 21094529, 26622774
- IP
Supplier Data
Immunoprecipitation - Anti-PU.1/Spi1 antibody [EPR25123-110] (AB302623)
PU.1/Spi1 was immunoprecipitated from 0.35 mg THP-1 (human monocytic leukemia monocyte), whole cell lysate 10 µg with ab302623 at 1/30 dilution (2µg in 0.35mg lysates). Western blot was performed on the immunoprecipitate using ab302623 at 1/1000 dilution. VeriBlot for IP secondary antibody(HRP)(ab131366) was used at 1/5000 dilution.
Lane 1 : THP-1 (human monocytic leukemia monocyte), whole cell lysate 10 µg
Lane 2 : ab302623 IP in THP-1 whole cell lysate
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab302623 in THP-1 whole cell lysate
Blocking and dilution buffer and concentration : 5% NFDM/TBST.
All lanes:
Immunoprecipitation - Anti-PU.1/Spi1 antibody [EPR25123-110] (ab302623) at 1/30 dilution
All lanes:
THP-1 (human monocytic leukemia monocyte), whole cell lysate
Secondary
All lanes:
Immunoprecipitation - VeriBlot for IP Detection Reagent (HRP) (<a href='/products/reagents/veriblot-for-ip-detection-reagent-hrp-ab131366'>ab131366</a>) at 1/5000 dilution
Predicted band size: 31 kDa
Observed band size: 31 kDa
false
Exposure time: 3min
- WB
Lab
Western blot - Anti-PU.1/Spi1 antibody [EPR25123-110] (AB302623)
Exposure time : Lane 1-2 : 180 seconds; Lane 3-4 : 20 seconds
In Western blot, Anti-GAPDH antibody [EPR16891] - Loading Control (ab181602) staining at 1/1000000 dilution.
ab76543 is more sensitive than ab302623 in WB testing.
Lanes 1 - 2:
Western blot - Anti-PU.1/Spi1 antibody [EPR25123-110] (ab302623) at 1/1000 dilution
Lanes 1 - 4:
Western blot - Anti-PU.1/Spi1 antibody [EPR25123-110] (BSA and Azide free) (<a href='/products/primary-antibodies/pu1-spi1-antibody-epr25123-110-bsa-and-azide-free-ab302624'>ab302624</a>) at 1/1000 dilution
Lanes 3 - 4:
Western blot - Anti-PU.1/Spi1 antibody [EPR3158Y] (<a href='/products/primary-antibodies/pu1-spi1-antibody-epr3158y-ab76543'>ab76543</a>) at 1/1000 dilution
Lanes 1 and 3:
Daudi whole cell lysate at 20 µg
Lanes 2 and 4:
Raji whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 31 kDa
Observed band size: 37-42 kDa
false
- WB
Supplier Data
Western blot - Anti-PU.1/Spi1 antibody [EPR25123-110] (AB302623)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
Negative control : HeLa (PMID : 27010793)
This blot was developed using a high sensitivity ECL substrate. The high-sensitivity ECL substrate used allows for the detection of proteins in the mid-femtogram range.
All lanes:
Western blot - Anti-PU.1/Spi1 antibody [EPR25123-110] (ab302623) at 1/1000 dilution
Lane 1:
THP-1 (human monocytic leukemia monocyte), whole cell lysate at 20 µg
Lane 2:
U937 (human histiocytic lymphoma monocyte), whole cell lysate at 20 µg
Lane 3:
Daudi (human Burkitts lymphoma lymphoblast), whole cell lysate at 20 µg
Lane 4:
HeLa (human cervix adenocarcinoma epithelial cell), whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Observed band size: 31 kDa
true
Exposure time: 3min
- ChIC/CUT&RUN-seq
Lab
ChIC/CUT&RUN sequencing - Anti-PU.1/Spi1 antibody [EPR25123-110] (AB302623)
ChIC/CUT&RUN was performed using a pAG-MNase at a final concentration of 700 ng/mL, 2.5 x 10^5 THP-1 (Human monocytic leukemia monocyte) cells and 5 µg of ab302623 [EPR25123-110]. The resulting DNA was sequenced on the Illumina NovaSeq 6000 to a depth of 10 million reads. The negative IgG control ab172730 is also shown. The University of Geneva owns patents relevant to ChIC (Chromatin Immuno-Cleavage) methods."
- ChIC/CUT&RUN-seq
Lab
ChIC/CUT&RUN sequencing - Anti-PU.1/Spi1 antibody [EPR25123-110] (AB302623)
ChIC/CUT&RUN was performed using a pAG-MNase at a final concentration of 700 ng/mL, 2.5 x 10^5 THP-1 (Human monocytic leukemia monocyte) cells and 5 µg of ab302623 [EPR25123-110]. The resulting DNA was sequenced on the Illumina NovaSeq 6000 to a depth of 10 million reads. The negative IgG control ab172730 is also shown. The University of Geneva owns patents relevant to ChIC (Chromatin Immuno-Cleavage) methods."
- ChIC/CUT&RUN-seq
Lab
ChIC/CUT&RUN sequencing - Anti-PU.1/Spi1 antibody [EPR25123-110] (AB302623)
ChIC/CUT&RUN was performed using a pAG-MNase at a final concentration of 700 ng/mL, 2.5 x 10^5 THP-1 (Human monocytic leukemia monocyte) cells and 5 µg of ab302623 [EPR25123-110]. The resulting DNA was sequenced on the Illumina NovaSeq 6000 to a depth of 10 million reads. The negative IgG control ab172730 is also shown. The University of Geneva owns patents relevant to ChIC (Chromatin Immuno-Cleavage) methods."
反应性数据
产品详情
Want a custom formulation?
This antibody clone is manufactured by Abcam. If you require a custom buffer formulation or conjugation for your experiments, please contact orders@abcam.com
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
性能和储存信息
形式
纯化工艺
存储溶液
运输条件
推荐的短期储存时间
推荐的短期储存条件
推荐的长期储存条件
分装信息
储存信息
补充信息
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
PU.1 influences the development and function of various blood cells including macrophages neutrophils and B-cells. It is essential for the regulation of genes involved in immune responses cell proliferation and survival. PU.1 functions as part of a larger transcriptional regulatory complex and often partners with other transcription factors and coactivators to exert its effects. This cooperation allows precise gene expression control in specific cell lineages.
Pathways
Expression of PU.1 is critical in the hematopoietic development pathway and the immune response pathway. It closely interacts with other transcription factors like GATA-1 and C/EBPα forming a network that affects hematopoietic lineage commitment. Within these pathways PU.1 constantly coordinates signals that influence progenitor cell fate and differentiation ensuring a balanced proportion of cell types within the blood.
产品实验方案
- Visit the General protocols
- Visit the Troubleshooting
靶点信息
文献 (5)
Recent publications for all applications. Explore the full list and refine your search
Biology direct 20:73 PubMed40551156
2025
Applications
Unspecified application
Species
Unspecified reactive species
Bone research 13:47 PubMed40229258
2025
Applications
Unspecified application
Species
Unspecified reactive species
Journal for immunotherapy of cancer 12: PubMed39455096
2024
Applications
Unspecified application
Species
Unspecified reactive species
American journal of cancer research 14:1139-1156 PubMed38590399
2024
Applications
Unspecified application
Species
Unspecified reactive species
Molecular carcinogenesis 63:448-460 PubMed38037991
2023
Applications
Unspecified application
Species
Unspecified reactive species
Abcam Product Promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com